A Phase IIa Trial of the New Tuberculosis Vaccine, MVA85A, in HIV- and/or <i>Mycobacterium tuberculosis</i> –infected Adults - Concepedia

Concepedia

Publication | Open Access

A Phase IIa Trial of the New Tuberculosis Vaccine, MVA85A, in HIV- and/or <i>Mycobacterium tuberculosis</i> –infected Adults

DOI Full Paper Access

86

Citations

33

References

2012

Year

Thomas J. Scriba, Michèle Tameris, Erica Smit, Linda van der Merwe, E. Jane Hughes, Blessing Kadira, Katya Mauff, Sizulu Moyo, Nathaniel J. Brittain, Alison M. Lawrie,

American Journal of Respiratory and Critical Care Medicine

Abstract

MVA85A was safe and immunogenic in persons with HIV and/or M.tb infection. These results support further evaluation of safety and efficacy of this vaccine for prevention of TB in these target populations.

References

	Year	Citations

Page 1